The stock price of Nevro (NASDAQ: NVRO), a medical devices company, has seen a 7% drop over the last five trading days, despite the company announcing positive findings from its spinal cord ...

After Nevro Corp. (NYSE: NVRO), a medical device company focused on pain management, shared a number of corporate updates with investors, its shares rose 35% as of 10:55 a.m. EDT on Wednesday. Nevro ...

After the bell on Wednesday, Nevro told investors that third-quarter revenue reached $100.2 million, which was $7.9 million more than the average analyst was expecting. On the bottom line, the ...

In the last three months, 6 analysts have published ratings on Nevro (NYSE:NVRO), offering a diverse range of perspectives from bullish to bearish. The table below provides a snapshot of their recent ...

The medical device maker's fourth-quarter results thrashed analysts' estimates. Investors were likely more concerned with the apparently growing influence of an activist investor. For the fourth ...

After inking a deal worth up to $75 million to acquire joint pain devicemaker Vyrsa Technologies late last year, Nevro now appears to be trying to lessen the impact of those costs on its bottom line.

On April 3, 2025, Nevro Corp. filed a notice of data breach with the Attorney General of Texas after discovering that information in the company’s possession was subject to unauthorized access. In ...

Nevro is bringing artificial intelligence to its spinal cord stimulation solutions. The Redwood City, CA-based company said it won FDA approval for the HFX iQ with HFX AdaptivAI - a responsive, ...

First Randomized Controlled Trial Specifically Powered to Assess Restoration of Neurological Function in Patients with Intractable Painful Diabetic Neuropathy Breakthrough Device Designation Provides ...

(RTTNews) - Nevro Corp. (NVRO), announced its preliminary fourth-quarter and full-year 2023 revenue results. The company also announced a restructuring, including laying off 5% of its workforce, that ...

REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ -- Nevro Corp. (NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, ...